CDKN2A and carcinoma: Specific incidences or prevalences of HPV-positive tumours are not yet included in the German cancer registries, which is why the incidence of HPV-associated OPSCCs is often determined by the proportion of HPV/p16-positive carcinomas in relation to the total number of all OPSCCs.